Refine by
Eluting Stent Manufacturer
29 companies found
Manufacturerbased inChampionsGate, FLORIDA (USA)
Our purpose is to improve health of the patients all around the world with our strong, hardworking, dedicated and clinically driven biomedical solutions team. Our products and technologies are mostly focused on endovascular treatment solutions with ...
Atlas? is a coronary balloon-expandable Stainless Steel stent system consisting of everolimus particles. It is indicated for de novo and in-stent restenotic lesions in patients with coronary artery disease – including acute coronary syndrome ...
Manufacturerbased inCarpinteria, CALIFORNIA (USA)
Our comprehensive technical capabilities range from the design and manufacture of minimally invasive, catheter, and handheld technology to the development and production of medical components utilizing advanced materials and processes. We lead the ...
A variety of specialized materials are being used in today’s MedTech environment. Many of these materials are only made suitable for the intended finished use by applying a customized surface treatment. These treatments can result in reduced ...
Manufacturerbased inFranklin Lakes, NEW JERSEY (USA)
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research ...
Tepha is developing fully absorbable stents and coatings made from TephaFLEX® material. This could allow for local drug elution while leaving no permanent residual polymer, which might address the issue of late ...
Manufacturerbased inRanga Reddy, INDIA
Relisys Medical Devices Limited is one of the world’s leading manufacturer of cardiovascular medical devices including Coronary Stents Systems - both Bare Metal Stent Systems & Drug Eluting Stent Systems, PTCA Balloons Catheters, Angiographic ...
Highlighting Features: • Pristine+ elutes Everolimus drug which is the most preferred drug by most of the interventional cardiologists • The basic stent platform for Pristine+ is L605 Cobalt Chromium ...
Manufacturerbased inLeeds, UNITED KINGDOM
Founded in 2009, Leeds-based Arterius is developing a next-generation bioresorbable cardiovascular scaffold (stent) with an emerging market-leading clinical profile. The founding directors have significant experience in the development of medical ...
Arterius has developed a polymer-based bioresorbable scaffold (or “BRS”) ArterioSorb™ that is intended to: Match the ease of delivery of Bare Metal Stent (BMS) and Drug Eluting ...
Manufacturerbased inSurat, INDIA
SMT is a global medical device company committed to making advance medical technologies accessible to everyone around the world. With a presence in over 69 countries, SMT has achieved recognition from the Government of India for its tremendous ...
Supraflex Cruz is an amalgamation of the best-in-class features like lowest strut thickness (60 μm), biodegradable polymer and offers an extensive size ...
Manufacturerbased inSingapore, SINGAPORE
For more than 25 years, the Biosensors International Group (“Biosensors”) has been developing and marketing critical care catheter systems and related devices used during heart surgery and intensive care treatment. Continually striving to be at the ...
In Evidence Based Medicine We Trust: At Biosensors International, innovation and clinical evidence is our driving force. We don’t just bring innovative and unique coronary stents to the market, we conduct robust landmark clinical trials to ...
Manufacturerbased inMumbai, INDIA
Established in 2009, Veritas Bioventions Pvt Ltd is a Medical Devices Company, specialized in development of innovative products aimed at improving the quality of human life. We have state of art manufacturing facilities designed with scientific ...
A new dimension of Hybrid Stent design – Greater flexibility and trackability. 65u stent strut thickness – Great scaffolding and visibility under fluoroscopy. ...
Manufacturerbased inWinsen, GERMANY
amg International GmbH develops, manufactures and sells on a world-wide basis stents, stent implantation systems and balloon catheters as well as auxiliary products such as guide wires and inflation devices, which are used primarily in the field of ...
The ITRIXII Sirolimus-Eluting Coronary Stent Implantation System is the first carbonized stent (Inert Carbon Technology) with a completely biodegradable polymer coating which contains Sirolimus ...
Manufacturerbased inHorsham, UNITED KINGDOM
Veryan has developed innovative technology to improve the performance of vascular stents by adopting the principle of biomimicry; developing structures that imitate those occurring naturally. Veryan’s vascular biomimetic stent technology involves ...
The Challenge: Peripheral Arterial Disease. People are living longer and with an increase in the incidence of obesity, diabetes and other contributing factors, claudication may cause substantial tissue changes and, in some scenarios, can lead to ...
Manufacturerbased inShanghai, CHINA
MicroPort is a global medical devices company, founded on the belief that every person has the right to high quality medical treatments and to live longer and healthier lives. All our solutions are designed to deliver on that belief. Our close ...
CoCr Stent Platform. Reliable durable polymer-Styrene Butylenes Styrene. Uniform sine wave design provides uniform support strength and ...
Manufacturerbased inWinsen, GERMANY
Stron Medical was launched in 2010 as a product line of QualiMed. With an impressive range of innovative products and a committed team of sales professionals, Stron Medical provides end-to-end solutions within Germany. QualiMed was found in 1997 as ...
The GALAXY Rapamycin-Eluting Coronary Stent System is the first carbonized stent (Inert Carbon Technology) with a completely biodegradable polymer coating which contains Rapamycin (Rapasorb™) ...
Manufacturerbased inFaridabad, INDIA
Founded in 2007, Newtech Medical Devices is Delhi-NCR, India based one of the leading manufacturing Company with CE and ISO compliance. Newtech develops, manufactures, markets & supports cutting edge vascular access devices and accessories to meet ...
The Insistent Sirolimus eluting stent system with biodegradable polymer is a combination product comprised of two regulated components: a device (a coronary stent system) and a drug product (a ...
Manufacturerbased inMiami Lakes, FLORIDA (USA)
Cordis is an independent, customer-focused provider of interventional cardiovascular technologies. During our 60-year history we’ve established a legacy of pioneering breakthrough technologies, including the first guiding catheters and coronary drug ...
Manufacturerbased inPark City, UTAH (USA)
N8 Medical, LLC (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins. These proprietary ceragenin compounds impart unique properties ...
Ceragenins are synthetic small molecules that can be manufactured in large scale and, unlike endogenous antimicrobial peptides, are not subject to proteolytic degradation. Over 100 ceragenins have been synthesized to date. Ceragenins consist of a ...
Manufacturerbased inVienna, AUSTRIA
P+F Products + Features GmbH is a medical technology company focused on research, development, and manufacture of innovative minimally invasive solutions in the field of cardiology. Our R&D capabilities are the foundation of our approach to ...
The EFIL+ Sirolimus Eluting Stent System is a combination product comprised of two regulated components: a device (a coronary stent system) and a drug product (a formulation of Sirolimus contained ...
Manufacturerbased inEden Prairie, MINNESOTA (USA)
Surmodics’ leadership in surface technologies dates to our development of the drug-delivery coating for the first drug-eluting stent. Since then, we’ve consistently pioneered breakthrough lubricious, hemocompatible, and drug-delivery COATINGS for ...
Manufacturerbased inBonn, GERMANY
CARDIONOVUM, a medical technology company based in Bonn, Germany, develops and commercializes innovative medical devices such as the new generation of DCB and drug-eluting stents for the treatment of coronary and peripheral artery disease. The ...
Unmatched XLIMUS clinical performance. The ultimate DES for complex artery lesions. XLIMUS is considered as the ultimate coronary DES stent system to treat complex coronary artery disease by reaching and crossing the most challenging ...
Manufacturerbased inCarlsbad, CALIFORNIA (USA)
CeloNova BioSciences, Inc. is developer and manufacturer of a portfolio of novel surfaced coated technologies, including the proprietary Polyzene-F nanocoating. This next-generation nanocoating is the result of years of rigorous scientific research ...
COBRA PzF NCS is the world’s first non-drug eluting, nanocoated stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT ...
Manufacturerbased inHechingen, GERMANY
Founded in 2000 in Germany, Translumina is a global interventional cardiovascular devices company with an ambition to deliver world-class products and services. We are a fully integrated product development and manufacturing company with ...
The Translumina Yukon drug-eluting stent product family, coated with Rapamycin (Sirolimus) and the biodegradable component polylactide (PLA), has an excellent history of pre-clinical and long-term clinical ...